Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder

PHASE2TerminatedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Major Depressive Disorder
Interventions
DRUG

DOV 21, 947

Capsules, 25 mg, 2 capsules (1 Active/1 Placebo) BID, 2 weeks Capsules, 25 mg, 2 capsules (2 Active) BID, 2 weeks

DRUG

Placebo

Capsules,25 mg,BID,6weeks

Trial Locations (26)

1100

Klinika za psihijatriju Vojnomedicinske Akademije, Velgrade

10021

Social Psychiatry Research Institute, New York

10312

Richmond Behavorial Associates, Staten Island

11000

Institut za mentalno zdravlje Palmoticeva 37, Belgrade

Institut za psihijatriju KCS, Belgrade

11223

Brooklyn Medical Institute, Brooklyn

18503

Scranton Medical Institutes, Scranton

19139

CRI Worldwide, LLC, Philadelphia

34000

Klinika za neurologiju i psihijatriju, Kragujevac

110084

Spitalul Judetean Arges, Piteşti

130081

Cabinetul Medical Lorentina 2102 S.R.L., Târgovişte

410154

Spitalul Clinic de Neurologie si Psihiatrie Oradea, Oradea

540139

Spitalul Clinic Judetean de Urgenta Targu Mures, Târgu Mureş

610136

Spitalul Judetean de Urgenta Piatra Neamt, Piatra Neamţ

700282

"Spitalul Clinic de Psihiatrie Socola", Lasi

06360

Comprehensive Psychiatric Care, Norwich

01103

Future Care Studies, Springfield

08002

Center for Emotional Fitness, Cherry Hill

08021

CRI Worldwide, LLC, Clementon

08540

Princeton Medical Institute, Princeton

010604

SC Corpores Sana Medical SRL, Bucharest

020125

"Spitalul Clinic Colentina, Ambulator Specialitate, Sectia Psihiatrie", Bucharest

041915

"Spitalul Clinic de Psihiatrie Prof. Dr. Alexandru Obregia, pavilion III", Bucharest

"Spitalul Clinic de Psihiatrie Prof. Dr. Alexandru Obregia, Pavilion IV", Bucharest

"Spitalul Clinic de Psihiatrie Prof. Dr. Alexandru Obregia, Pavilion X", Bucharest

Unknown

"Spitalul Universitar de Psihiatrie Socola", Lasi

Sponsors
All Listed Sponsors
lead

DOV Pharmaceutical, Inc.

INDUSTRY